Literature DB >> 1823839

Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.

M Fischer1.   

Abstract

Fourteen patients with chromaffin tumors were treated with [131]metaiodobenzylguanidine (131I-MIBG); 13 of them suffered from malignant and one from benign pheochromocytoma. In all patients clinical symptoms were improved. In some of these patients tumor shrinkage was observed. In one patient surgery of all tumor tissue was made possible by 131I-MIBG treatment. As shown in one patient, close follow-up is necessary in any case because remnant tumor tissue may start growing again after a long period of rest.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1823839

Source DB:  PubMed          Journal:  J Nucl Biol Med        ISSN: 0368-3249


  2 in total

Review 1.  The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.

Authors:  K C Loh; P A Fitzgerald; K K Matthay; P P Yeo; D C Price
Journal:  J Endocrinol Invest       Date:  1997-12       Impact factor: 4.256

2.  Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.

Authors:  P Pujol; J Bringer; P Faurous; C Jaffiol
Journal:  Eur J Nucl Med       Date:  1995-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.